Inventor · disambiguated record
William F. Brubaker
Also filed as: BRUBAKER JR WILLIAM FREDERICK · BRUBAKER WILLIAM · BRUBAKER WILLIAM F · BRUBAKER WILLIAM FREDERICK
10 granted patents·5 pending applications·52 citations·filing 1997–2023
87Inventor score
Files withFARMINGTON PHARMA DEV4MEMORY PHARM CORP4ULTRAGENYX PHARMACEUTICAL INC3SCHUMACHER RICHARD A2BAYER AG1
Top patents by PatentIndex Score
15 records- 0187US6699890B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Mar 2, 2004·21 cites·75 claims
- 0286US11753369B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Granted Sep 12, 2023·1 cites·20 claims
- 0383US9617230B2Creatine prodrugs, compositions and methods of use thereofFARMINGTON PHARMA DEV·Filed 2015·Granted Apr 11, 2017·5 cites·21 claims
- 0482US11332438B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted May 17, 2022·2 cites·23 claims
- 0582US10344007B2Creatine prodrugs, compositions and methods of use thereofFARMINGTON PHARMA DEV·Filed 2017·Granted Jul 9, 2019·4 cites·13 claims
- 0679US11021501B2Creatine phosphate analog prodrugs, compositions and methods of use thereofFARMINGTON PHARMA DEV·Filed 2016·Granted Jun 1, 2021·2 cites·22 claims
- 0777US2024092731A1Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 0874US11407722B2Creatine prodrugs, compositions and methods of use thereofFARMINGTON PHARMA DEV·Filed 2019·Granted Aug 9, 2022·1 cites·20 claims
- 0970US7405230B2Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogsMEMORY PHARM CORP·Filed 2003·Granted Jul 29, 2008·5 cites·39 claims
- 1058US7205320B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 17, 2007·2 cites·71 claims
- 1155US2011046146A9Phosphodiesterase 4 inhibitorsSCHUMACHER RICHARD A·Filed 2006·Application pending·0 cites
- 1253US2025275966A1Gabaa receptor modulator salts, particles, and uses thereofENGRAIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1350US2009048255A1Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogsSCHUMACHER RICHARD A·Filed 2008·Application pending·0 cites
- 1447US2003149052A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Application pending·0 cites
- 1545US5939583ASubstituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Aug 17, 1999·9 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →